Scribeable vs Tali AI:
Tali is built in Canada for Canadian primary care, and it shows. Scribeable is built for US practices: US dollar pricing, US revenue coding in the note, and a direct eClinicalWorks connection.
Why Physicians Switch from Tali AI
Tali's paid plans are priced in Canadian dollars, and its pricing page shows two different price sets (Nov 2026)
The free Personal plan includes 5 AI scribes a month
HCC risk adjustment and MIPS quality measures are not stated on tali.ai as of Nov 2026
Built for Canada
Tali calls itself the only Canadian-built AI platform designed for primary care workflows. It integrates with Accuro, PS Suite, Med Access, and other Canadian EMRs, says data is stored and processed within Canada, and advertises PHIPA, PIPEDA, HIPAA, and SOC 2 Type II. For a Canadian clinic, that is a real advantage, and Scribeable does not try to match it.
Built for US Billing
A US note carries revenue. Scribeable Pro puts ICD-10 codes in the note with their supporting text, sets the E&M level, captures HCC V28 against an 8,000+ entry crosswalk, and scores MIPS quality measures from the same note. Tali says it identifies billing codes from the encounter; HCC and MIPS are not stated on tali.ai as of Nov 2026.
Same Patient. Same Encounter.
See why physicians say Scribeable notes are “actually usable” — with integrated risk scores, billing codes, and clinical reasoning that typical AI scribes simply don’t generate.
HPI
62 y/o male presents with chest pain for 2 hours. Substernal, pressure-like, radiating to left arm. Associated with diaphoresis and shortness of breath. Pain started while climbing stairs. Patient has history of HTN, DM2, and hyperlipidemia. Takes lisinopril, metformin, and atorvastatin. Denies recent illness or trauma.
Assessment & Plan
*Note examples are illustrative representations based on common AI documentation patterns. “Typical AI Scribe” represents composite characteristics of standard tools and does not depict any specific product. Patient scenarios are entirely fictional. Clinical notes should always be reviewed by a licensed provider.
AI Medical Scribe Note Quality Comparison
Scribeable produces clinically enriched notes with integrated risk calculators (HEART Score, CHA₂DS₂-VASc, Wells PE, PHQ-9, Caprini VTE), automated billing code optimization (E&M levels, HCC/RAF capture, CPT codes), dangerous diagnosis exclusion documentation, evidence-based prescribing citations, CMS compliance for operative reports, HEDIS care gap tracking, and MIPS quality measure documentation. Typical AI scribes produce basic notes without these advanced clinical features.
ED Chest Pain: 62-year-old male presenting with substernal chest pressure, diaphoresis, and exertional dyspnea
HPI: 62 y/o male presents with 2 hours of substernal chest pressure, rated 8/10, radiating to left arm and jaw. Onset during exertion (climbing stairs). Associated with diaphoresis and exertional dyspnea. Pressure-like quality, unrelieved by rest. No pleuritic component, no positional variation, no reproducibility with palpation. Risk factors: HTN (10 years), DM2 (8 years), hyperlipidemia, 30-pack-year smoking history (quit 5 years ago), family history of MI (father at age 58). Current medications: lisinopril 20mg daily, metformin 1000mg BID, atorvastatin 40mg daily. Denies cocaine use, recent immobilization, or prior VTE.
Assessment & Plan: 1. Acute Chest Pain — High-risk presentation HEART Score: 7 (High Risk) - History: moderately suspicious (2), EKG: non-specific ST changes (1), Age: >65 (2), Risk factors: ≥3 (2), Troponin: pending initial (0) - Risk stratification: >12% 6-week MACE event rate → full ACS workup - Serial troponins q3h, 12-lead EKG (initial + repeat at 60 min) - ASA 325mg PO administered, heparin drip per ACS protocol - Cardiology consulted for probable cath lab activation Dangerous Diagnosis Exclusion: - STEMI: No ST elevation on initial EKG — serial monitoring - Aortic dissection: No tearing quality, no pulse differential, no mediastinal widening on CXR - PE: Low pretest probability (Wells PE: 1.5) — no immobilization, no prior VTE, no hemoptysis 2. Hypertension — BP 168/94 on arrival, improved to 142/88 post-NTG - Continue home lisinopril, recheck prior to disposition 3. DM2 — Glucose 186 on arrival - Hold metformin (contrast exposure risk), sliding scale insulin PRN
Cardiology Consult: 71-year-old female with new-onset atrial fibrillation and decompensated heart failure
HPI: 71 y/o female with known HFrEF (EF 35% on TTE 6 months ago), HTN, DM2, and CKD Stage 3a (baseline Cr 1.4), consulted for new-onset atrial fibrillation with RVR. Progressive exertional dyspnea (NYHA II → IV over 2 weeks), 3-pillow orthopnea (new), PND, and 4+ pitting edema to knees bilaterally. Weight gain of 8 lbs over 2 weeks. Triggers explored: dietary indiscretion (holiday meals), medication non-adherence (ran out of furosemide 10 days ago). No prior AF history, no palpitations previously. Denies chest pain, syncope, or presyncope.
Assessment & Plan: Reason for Consult: New-onset atrial fibrillation with RVR in setting of acute decompensated HFrEF. Requesting Service: Internal Medicine (Dr. Patel) 1. New-onset Atrial Fibrillation with RVR CHA₂DS₂-VASc Score: 5 (Female sex, age ≥75, HTN, DM, HF) - Stroke risk: 6.7%/year → strong anticoagulation indication - Rate control: avoid diltiazem (negative inotropy in HFrEF) → amiodarone 150mg IV bolus then 1mg/min × 6h - Anticoagulation: apixaban 5mg BID (preferred over warfarin given age + fall risk) - TEE prior to any cardioversion attempt if AF duration uncertain - HAS-BLED: 2 (HTN, age) — acceptable bleeding risk 2. Acute Decompensated Heart Failure (ADHF) NYHA Functional Class: IV (dyspnea at rest) - IV furosemide 80mg BID (2.5× home oral dose), net negative 1-1.5L/day - Carvedilol held (acute decompensation), restart when euvolemic - Add sacubitril/valsartan when stable (PARADIGM-HF indication: EF ≤40% on ACEi) - BNP trend: 1,840 → monitor for response to diuresis 3. CKD Stage 3a — Cr 1.4 (baseline), monitor with aggressive diuresis - KDIGO risk: moderate — monitor Cr/K daily with diuresis
Operative Note: Right total knee arthroplasty in 68-year-old male with severe tricompartmental osteoarthritis
Operative Note: Preoperative Diagnosis: Right knee severe tricompartmental osteoarthritis (Kellgren-Lawrence Grade IV) Postoperative Diagnosis: Same Procedure: Right total knee arthroplasty Surgeon: Dr. James Morrison (attending — present and scrubbed for entire case) Assistant: Dr. Chen (PGY-4) Anesthesia: Spinal with sedation (Dr. Rivera) Implants: Smith & Nephew Legion CR, Size 5 femoral / Size 4 tibial / 10mm poly insert EBL: 150 mL Tourniquet Time: 62 minutes (pneumatic, 275 mmHg) Specimens: Femoral and tibial bone cuts — to pathology Complications: None Findings: Severe tricompartmental degenerative changes with exposed subchondral bone medially, grade III chondromalacia laterally, intact PCL
Post-Operative Plan: 1. Weight Bearing: WBAT right LE with front-wheeled walker 2. DVT Prophylaxis: Enoxaparin 40mg SQ daily × 14 days + mechanical (SCDs while inpatient) 3. Pain: Multimodal — scheduled acetaminophen 1g Q6h, meloxicam 15mg daily, tramadol 50mg Q6h PRN (max 14 days) 4. Antibiotics: Ancef 2g IV × 24h post-op 5. PT: Initiate POD0 PM — CPM machine, active/passive ROM, gait training 6. Follow-up: 2 weeks (staple removal + wound check), 6 weeks (X-ray + ROM assessment) 7. VTE Risk: Caprini Score 7 (High Risk) — extended pharmacologic prophylaxis indicated
Primary Care: 55-year-old female Medicare Advantage patient with DM2, HTN, depression, and overdue preventive care
HPI: 55 y/o female Medicare Advantage patient presenting for chronic disease management follow-up. Last visit 3 months ago. Diabetes (DM2, 8 years): A1c 8.2% (up from 7.6%), reports adherence but dietary indiscretion during holidays. Home glucose logs show fasting 140-180 range. No hypoglycemic episodes. Denies polyuria, polydipsia, vision changes, or foot numbness. Last diabetic eye exam: 14 months ago (overdue). Last podiatry visit: never. Hypertension (12 years): Home BP readings averaging 135-145/85-90. Taking lisinopril 20mg daily consistently. Depression (MDD, recurrent): PHQ-9 score today: 14 (moderately severe). Persistent low mood, anhedonia, poor sleep (initial insomnia), decreased concentration. On sertraline 50mg × 6 months with partial response. Denies SI/HI, denies alcohol or substance use. Columbia Suicide Severity: negative for ideation and behavior.
Assessment & Plan: 1. DM2, Uncontrolled (A1c 8.2%) — HCC 19 - Add empagliflozin 10mg daily (SGLT2i — CV and renal benefit, EMPA-REG OUTCOME indication) - Continue metformin 500mg BID (not escalating given GI intolerance history) - Diabetic eye exam referral (overdue 2 months — HEDIS measure) - Podiatry referral for initial foot exam - Recheck A1c in 3 months, target <7% 2. Hypertension, Suboptimally Controlled — HCC (when with CKD/DM) - BP today 138/86 — above target of <130/80 (ACC/AHA for DM patients) - Increase lisinopril to 40mg daily - Home BP log review in 4 weeks 3. Major Depressive Disorder, Recurrent, Moderate — HCC 59 - PHQ-9: 14 (moderately severe) — partial response to sertraline 50mg - Increase sertraline to 100mg daily - Safety plan reviewed, crisis line provided (988) - Follow-up in 4 weeks, recheck PHQ-9 - If inadequate response → consider augmentation or psychiatry referral 4. Preventive Care Gaps Addressed: - Mammogram ordered (last: 26 months ago — HEDIS BCS measure) - Colonoscopy referral (age 55, average risk, never screened — HEDIS COL) - Tobacco screening: former smoker, quit 3 years — MIPS measure 226 - Annual flu vaccine administered today
Feature-by-Feature Comparison
Pricing & Access
| Feature | Scribeable | Tali AI |
|---|---|---|
| Published pricing with dollar amounts tali.ai/pricing lists paid plans in Canadian dollars, as of Nov 2026, and shows two different price sets on the same page. Scribeable lists a Free plan at $0 and Pro at $79 per month in US dollars | Yes | Yes |
| Free plan Tali's free Personal plan includes 5 AI scribes a month with no credit card. Scribeable has a Free plan: add your NPI and it writes notes from your recordings in your templates, with no monthly note cap. Codes, letters and Rounding are in Pro. New accounts start with 14 days of full Pro, up to 150 notes | Yes | Yes |
| Free trial before the first charge Tali offers a 14-day trial on its paid plans. Scribeable's trial is 14 days of full Pro, capped at 150 notes, with no credit card required | Yes | Yes |
US Clinical Intelligence
| Feature | Scribeable | Tali AI |
|---|---|---|
| Billing codes from the encounter Tali says it "identifies the appropriate billing codes from your encounter." Scribeable Pro puts ICD-10 codes in the note with their supporting text and sets the E&M level | Yes | Yes |
| HCC V28 risk-adjustment coding Not stated on tali.ai as of Nov 2026 | Yes | Not stated |
| MIPS quality measures checked in the note Not stated on tali.ai as of Nov 2026 | Yes | Not stated |
EHR & Data
| Feature | Scribeable | Tali AI |
|---|---|---|
| Direct eClinicalWorks connection eClinicalWorks is not in the integration list on tali.ai as of Nov 2026, which names Net Health, Practice Fusion, and Veradigm in the US | Yes | Not stated |
| Canadian EMR integrations (Accuro, PS Suite, Med Access and others) Tali lists integrations with Accuro, CHR, Healthquest, Med Access, Medesync, Profile, and PS Suite. Scribeable's Chrome extension inserts notes into web-based EHRs; it has no direct connection to these Canadian EMRs | No | Yes |
| Data stored in Canada Tali says data is stored and processed within Canada and advertises PHIPA and PIPEDA compliance. Scribeable keeps data in the US | No | Yes |
Competitor facts on this page are sourced to each company's own public site and verified between 2026-11-08 and 2026-11-09; see page source for the full citation list. Competitor capabilities and pricing may change after that date.
Pricing Comparison
Tali AI
Free Personal plan (5 AI scribes a month); paid plans priced in Canadian dollars
Contact for pricing
Both vendors list prices. Tali's pricing page was read on 2026-11-08; it shows two different sets of paid prices in CA$, so confirm the current rate with Tali. Scribeable Pro is $79/month in US dollars, with unlimited notes.
Each sentence drawn from the visit or the chart links back to where it came from, so you can check the note before you sign it.
Ratings and reviews
Which Should You Choose?
Choose Tali AI if you...
- Canadian clinicians on Accuro, PS Suite, Med Access, or another Canadian EMR
- Practices that need data stored and processed in Canada
- Clinicians who want Tali's free plan for a few scribed visits a month
Frequently Asked Questions
How much does Tali AI cost?
Does Tali AI work with eClinicalWorks?
Is Scribeable available in Canada?
Compare Other Alternatives
Looking for a shortlist instead? See Tali AI alternatives.
vs Dragon Copilot
Considering Microsoft Dragon Copilot, the product formerly sold as Nuance DAX? Here is a factual look at how Scribeable differs — on pricing transparency, who owns the account, and who each company answers to.
vs Nabla
Considering Nabla? Here is a factual look at how Scribeable differs — on pricing transparency and who owns the account.
vs Abridge
Considering Abridge? Here is a factual look at how Scribeable differs — on pricing transparency and who owns the account.
Start Your 14-Day Pro Trial
Compare Scribeable to Tali AI on your own terms. No sales call, no IT ticket.
14-day Pro trial, no credit card required. Everything in Pro, including Rounding, for up to 150 notes. To keep Pro after day 14, subscribe for $79/month plus applicable tax. If you don't, nothing is charged and your account moves to the Free plan once you add your NPI (until then it is read-only), with every note kept.
Scribeable vs Tali AI - AI Medical Scribe Comparison
Tali is built in Canada for Canadian primary care, and it shows. Scribeable is built for US practices: US dollar pricing, US revenue coding in the note, and a direct eClinicalWorks connection.
Why Physicians Switch from Tali AI
- Tali's paid plans are priced in Canadian dollars, and its pricing page shows two different price sets (Nov 2026)
- The free Personal plan includes 5 AI scribes a month
- HCC risk adjustment and MIPS quality measures are not stated on tali.ai as of Nov 2026
Why Choose Scribeable Over Tali AI
- Priced in US dollars: a Free plan at $0 and Pro at $79/month
- HCC V28 risk-adjustment coding and MIPS quality measures in the note
- Direct eClinicalWorks connection that reads the chart and sends the signed note into the chart
- 236 clinical calculators computed in code, not recalled by the model
Built for Canada
Tali calls itself the only Canadian-built AI platform designed for primary care workflows. It integrates with Accuro, PS Suite, Med Access, and other Canadian EMRs, says data is stored and processed within Canada, and advertises PHIPA, PIPEDA, HIPAA, and SOC 2 Type II. For a Canadian clinic, that is a real advantage, and Scribeable does not try to match it.
Built for US Billing
A US note carries revenue. Scribeable Pro puts ICD-10 codes in the note with their supporting text, sets the E&M level, captures HCC V28 against an 8,000+ entry crosswalk, and scores MIPS quality measures from the same note. Tali says it identifies billing codes from the encounter; HCC and MIPS are not stated on tali.ai as of Nov 2026.
Feature Comparison: Scribeable vs Tali AI
Pricing & Access
| Feature | Scribeable | Tali AI |
|---|---|---|
| Published pricing with dollar amounts | Yes | Yes |
| Free plan | Yes | Yes |
| Free trial before the first charge | Yes | Yes |
US Clinical Intelligence
| Feature | Scribeable | Tali AI |
|---|---|---|
| Billing codes from the encounter | Yes | Yes |
| HCC V28 risk-adjustment coding | Yes | Not stated |
| MIPS quality measures checked in the note | Yes | Not stated |
EHR & Data
| Feature | Scribeable | Tali AI |
|---|---|---|
| Direct eClinicalWorks connection | Yes | Not stated |
| Canadian EMR integrations (Accuro, PS Suite, Med Access and others) | No | Yes |
| Data stored in Canada | No | Yes |
Pricing Comparison
Scribeable: Free plan $0, Pro $79/month, published
Tali AI: Free Personal plan (5 AI scribes a month); paid plans priced in Canadian dollars
Both vendors list prices. Tali's pricing page was read on 2026-11-08; it shows two different sets of paid prices in CA$, so confirm the current rate with Tali. Scribeable Pro is $79/month in US dollars, with unlimited notes.
Which Should You Choose?
If you practice in Canada, on Accuro, PS Suite, or another Canadian EMR, and need data kept in Canada, Tali is built for you. If you are a US practice that needs HCC V28 and MIPS in the note, US dollar pricing, or a direct eClinicalWorks connection, Scribeable is the closer fit.
Frequently Asked Questions
How much does Tali AI cost?
Tali lists a free Personal plan with 5 AI scribes a month and paid plans priced in Canadian dollars with a 14-day trial. Its pricing page showed two different sets of paid prices on November 8, 2026, so confirm the current rate with Tali. Scribeable Pro is $79 a month in US dollars.
Does Tali AI work with eClinicalWorks?
eClinicalWorks is not in the integration list on tali.ai as of November 2026; in the US it names Net Health, Practice Fusion, and Veradigm. Scribeable connects to eClinicalWorks directly, reads the chart, and sends the signed note into the eCW chart.
Is Scribeable available in Canada?
Scribeable is built for US practices and keeps data in the US. If you need Canadian data residency or a direct connection to a Canadian EMR, Tali is designed for that.
Sources
Tali calls itself "Canada's Leading Ambient AI Scribe for EMRs," says it "identifies the appropriate billing codes from your encounter," lists Canadian EMR integrations plus Net Health, Practice Fusion, and Veradigm in the US, advertises HIPAA, PHIPA, and SOC 2 Type II, and says data is stored and processed within Canada.
Tali's pricing page lists a free Personal plan (5 AI scribes a month, no credit card) and paid plans priced in CA$ with a 14-day trial; the page shows two different sets of paid prices.
Scribeable pricing: Free plan $0, Pro $79/mo.
Explore More
Discover how Scribeable can help your practice with AI-powered clinical documentation